Publications
-
Ramos MA, Hernández C and Arranz B.
Iron dysregulation across the schizophrenia lifespan: A systematic review from prenatal risk to postmortem findings.
PSYCHIATRY RESEARCH . 362: 117193-117193.
-
Futhey NC, Vila-Rodriguez F, Stochmanski SJ, Gregory E, Honer WG, Arranz B, Ramos B, ANA ESCANILLA CASAL, Vera-Montecinos A, Cembrowski MS and Hirsch-Reinshagen V.
Integrated clinical and postmortem profiling in schizophrenia reveals a cognitive subtype linked to cerebrovascular disease.
Translational Psychiatry . 16(1): .
-
Sanchez-Autet M, Alfonso M, Hernandez C, Gonzalez-Blanco L, García-Portilla MP, Bernardo M, Anmella G, Amoretti S, Safont G and Arranz B.
Predictive value of C-reactive protein and hematologic ratios for metabolic syndrome in schizophrenia.
Spanish Journal of Psychiatry and Mental Health . : .
-
Anmella G, Amoretti S, Safont G, Meseguer A, Vieta E, Pons-Cabrera MT, Alfonso M, Hernández-Cera C, Sanchez-Autet M, Pérez-Baldellou F, González-Blanco L, García-Portilla MP, Bernardo M and Arranz B.
Intestinal permeability and low-grade chronic inflammation in schizophrenia: A multicentre study on biomarkers. Rationale, objectives, protocol and preliminary results.
Spanish Journal of Psychiatry and Mental Health . 18(4): 281-287. Number of citations: 3
-
Safont G, Garriga M, González-Rodríguez A, Amoretti S, Simón O, Solè E, Garcia-Rizo C, Arranz B, Vieta E and Bernardo M.
Maternity in women with schizophrenia and schizoaffective disorder
Spanish Journal of Psychiatry and Mental Health . 18(2): 106-110. Number of citations: 7
-
Safont G, Garriga M, Amoretti S, Cuesta MJ, Parellada M, González-Pinto A, Bergé D, Rodriguez-Jimenez R, Bejarano AR, Sarró S, Ibáñez Á, Usall J, Gutiérrez M, Vieta E, Arranz B, Berrocoso E, Verdolini N and Bernardo M.
Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance
Spanish Journal of Psychiatry and Mental Health . 18(2): 80-90. Number of citations: 2
-
San L, Arranz B, Romans C, García B, Coromina M, Ortiz S, Vilaplana M, Soto V, Ruth Villaescusa Portella and Alvarós J.
Patient-reported outcome measures to assess mental and physical health status, functionality, and quality of life in patients with major depression or schizophrenia
Journal of Patient-Reported Outcomes . 9(1): 4-4. Number of citations: 3
-
Ballasch I, López-Molina L, Galán-Ganga M, Sancho-Balsells A, Rodríguez-Navarro I, Borràs-Pernas S, Rabadan MA, Chen W, Pastó-Pellicer C, Flotta F, Maoyu W, Fernández-Irigoyen J, Santamaría E, Aguilar R, Dobaño C, Egri N, Hernandez C, Alfonso M, Juan M, Alberch J, Del Toro D, Arranz B, Canals JM and Giralt A.
Alterations of the IKZF1-IKZF2 tandem in immune cells of schizophrenia patients regulate associated phenotypes
Journal of Neuroinflammation . 21(1): 326-326.
-
González-Blanco L, Dal Santo F, García-Portilla MP, Alfonso M, Hernández C, Sánchez-Autet M, Anmella G, Amoretti S, Safont G, Martín-Hernández D, Malan-Müller S, Bernardo M and Arranz B.
Intestinal permeability biomarkers in patients with schizophrenia: Additional support for the impact of lifestyle habits
EUROPEAN PSYCHIATRY . 67(1): . Number of citations: 10
-
Ibáñez D, Condominas E, Haro JM, Vázquez IG, Radar-Mdd-Spain, Bailón R, Garcia E, Kontaxis S, Peñarrubia-María MT, Arranz B, Llaosa-Scholten R, Gardeñes L, Hotopf M, Matcham F, Lamers F, Penninx BWJH, Annas P, Folarin A, Narayan V, Antunes R and Siddi S.
Pre- and post-COVID 19 outbreak relationship between physical activity and depressive symptoms in Spanish adults with major depressive disorder: a secondary analysis of the RADAR-MDD cohort study.
Frontiers in Psychology . 15: 1436611-1436611.
